BillionToOne is a precision diagnostics company offering a prenatal cystic fibrosis and spinal muscular atrophy screening option that tests fetal cell-free DNA through a single tube of the mother’s blood. The Company operates a molecular counter platform that can accurately count the DNA molecules to the single-count level.
|HQ||Menlo Park, CA, US||Map|
|Employees (est.) (Jul 2021)||83||(+19%)|
BillionToOne total Funding
BillionToOne latest funding size
Time since last funding
|22 days ago|
|Y Combinator, Four Rivers Group, Hummingbird Ventures, HOF Capital, Fifty Years, Wei Guo, NewDo Venture, Pacific 8 Ventures, NeoTribe Ventures, UpHonest Capital, Norwest Venture Partners, Civilization Ventures, Libertus Capital, David Chan, 500 Startups Istanbul, 500 Istanbul|
BillionToOne has 394 Twitter Followers. The number of followers has increased 1.7% month over month and increased 3.1% quarter over quarter
When was BillionToOne founded?
BillionToOne was founded in 2016.
Who are BillionToOne key executives?
BillionToOne's key executives are Oguzhan Atay, David Tsao and Nipun Soni.
How many employees does BillionToOne have?
BillionToOne has 83 employees.
Who are BillionToOne competitors?
Competitors of BillionToOne include ReCode Therapeutics, RheoDx and VivoSensMedical.
Where is BillionToOne headquarters?
BillionToOne headquarters is located at 1455 Adams Dr #1130Menlo, Menlo Park.
Where are BillionToOne offices?
BillionToOne has an office in Menlo Park.
How many offices does BillionToOne have?
BillionToOne has 1 office.
Receive alerts for 300+ data fields across thousands of companies